Pandion Therapeutics Inc is a clinical-stage biopharmaceutical company. It is engaged in developing novel therapeutics to address the unmet needs of patients suffering from autoimmune diseases. The firm has combined a network-based conceptualization of the immune system in advanced protein engineering to develop TALON (Therapeutic Autoimmune reguLatOry proteiN) drug design and discovery platform. Its pipeline products are PT101, for the treatment of patients with moderate-to-severe ulcerative colitis and the treatment of patients with systemic lupus erythematosus; PT627; PT001; and others.

Related Companies

TickerCompanyChg %Mkt Cap

undefined Frequently Asked Questions

Q

How do I buy undefined (PAND) stock?

A

You can purchase shares of (: ) through any online brokerage.

View our list of the best stock brokerages.

Q

Who are undefined's (PAND) competitors?

A

There are no as such competitors for .

Q

What is the target price for undefined (PAND) stock?

A

There is no analysis for

Q

Current Stock Price for undefined (PAND)?

A

The stock price for (: ) is $ last updated Invalid Date.

Q

Does undefined (PAND) pay a dividend?

A

There are no upcoming dividends for .

Q

When is undefined (undefined:PAND) reporting earnings?

A

does not have any upcoming earnings scheduled.

Q

Is undefined (PAND) going to split?

A

There is no upcoming split for .

Q

What sector and industry does undefined (PAND) operate in?

A

is in the Consumer Discretionary sector and Multiline Retail industry. They are listed on the .